Healius Ltd (ASX: HLS) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
Healius Ltd Chart and Price Data
Fundamentals Data provided by Morningstar.
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
Healius Ltd (ASX: HLS)
Latest News
Broker Notes
Broker names 2 of the best ASX shares to buy now
Share Market News
5 things to watch on the ASX 200 on Wednesday
Dividend Investing
These 9 ASX 200 shares are going ex-dividend tomorrow
Investing Strategies
2 quietly achieving ASX shares to pounce on right now: Morgans
Broker Notes
Top brokers name 3 ASX shares to buy today
Share Gainers
Why A2 Milk, Deep Yellow, Healius, and IGO shares are racing higher
Earnings Results
Healius share price climbs as profit doubles in FY22
Share Market News
5 things to watch on the ASX 200 on Tuesday
Blue Chip Shares
2 blue chip ASX 200 shares analysts rate as buys
Share Market News
ASX 200 midday update: Big four banks rebound, Atlas Arteria's takeover update
Broker Notes
Leading brokers name 3 ASX shares to buy today
Share Fallers
These were the worst performing ASX 200 shares last week
Frequently Asked Questions
-
Yes, Healius has historically paid two fully franked shareholder dividends a year.
-
Healius has generally paid its shareholder dividends in March/April and September/October.
-
Healius Ltd listed on the ASX on 3 July 1998.
HLS ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About Healius Ltd
Healius Ltd (ASX: HLS) operates a network of pathology laboratories, diagnostic imaging centres, and day hospitals across Australia.
The company is Australia's second-largest pathology provider with around 2,000 collection sites and almost 100 pathology laboratories operating under a portfolio of brand names. The company says one in three pathology samples taken in Australia is tested in a Healius laboratory. It also operates around 150 imaging centres in public and private hospitals, medical centres, and community centres.
The company has identified its short-stay and day hospitals as a growth segment. It currently operates 15 day hospitals as well as four major IVF clinics.
